AccuRx, Inc is a biotech company focused on providing critically-needed technological solutions to pharmaceutical companies—a sustainable strategy to extend the useful lifetime of patent-protected blockbuster drugs, delaying the inevitable onslaught of generics; and a reliable laboratory test to predict the drug toxicity before embarking on expensive clinical trials.

The current business focus is on two lucrative segments within ophthalmic market: glaucoma and dry eye syndrome.